ATC code J02 Antimycotics for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup J02 is part of the anatomical group J Antiinfectives for systemic use.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QJ02.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

J02A Antimycotics for systemic use edit

J02AA Antibiotics edit

J02AA01 Amphotericin B
J02AA02 Hachimycin

J02AB Imidazole derivatives edit

J02AB01 Miconazole
J02AB02 Ketoconazole
QJ02AB90 Clotrimazole

J02AC Triazole and tetrazole derivatives edit

J02AC01 Fluconazole
J02AC02 Itraconazole
J02AC03 Voriconazole
J02AC04 Posaconazole
J02AC05 Isavuconazole
J02AC06 Oteseconazole

J02AX Other antimycotics for systemic use edit

J02AX01 Flucytosine
J02AX04 Caspofungin
J02AX05 Micafungin
J02AX06 Anidulafungin
J02AX07 Ibrexafungerp
J02AX08 Rezafungin acetate

References edit

  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code J02". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QJ02". WHO Collaborating Centre for Drug Statistics Methodology.